Skip to main content
Top of the Page
ABT

Reports and Publications

The Regenerative Medicine Value Chain: The pathway from discovery to patient delivery

Regenerative medicine (RM) promises to deliver ground-breaking therapies to Australian patients, with innovative approaches targeting a wide range of conditions including rare genetic diseases, cancers, chronic diseases, and organ damage.

Click here


Back to Top